Table 1.

Demographic, clinical and serological findings in MOG IgG positive patients with NMDAR encephalitis

Ref	Demographics			Clinics					Serum		CSF
	Patient Number	Age	Sex	Graus criteria fulfilleda	Demyelinating episodes, nb	Follow-up, Moc	Time E – MOG + , Mo	DE symptoms	MOG-IgG status	NMDAR-IgG status	MOG-IgG status	NMDAR-IgG status	OCB status	WBC/µl
[3]	1	48	F	Yes	2	60	18	Yes	positive	positive	positive	positive	positive	150
[3]	2	17	M	Yes	2	9	3	Yes	n.a	Not applicable	positive	positive	negative	3
[3]	3	27	F	Yes	5	108	-48	Yes	positive	negative	positive	positive	positive	66
[3]	4	34	M	Yes	2	22	3	Yes	positive	negative	positive	positive	negative	164
[3]	5	10	M	Yes	1	144	-96	Yes	positive	negative	positive	positive	negative	9
[3]	6	29	M	Yes	1	41	36	Yes	positive	n.a	positive	positive	negative	0
[3]	7	38	M	Yes	2	60	-22	Yes	positive	negative	positive	positive	negative	2
[3]	8	4	F	Yes	1	7	0	Yes	positive	n.a	positive	positive	positive	n.a
[3]	9	6	M	Yes	1	2,5	0	Yes	positive	negative	positive	positive	positive	43
[15]	10	9	F	Yes	1	18	0.5	Yes	positive	positive	positive	positive	negative	44
[13]	11	31	M	No	2	15	0	Yes	positive	negative	n.a	positive	negative	8
[12]	12	54	M	Yes	0	3	0	Yes	positive	n.a	n.a	positive	negative	28
[8]	13	3	F	Yes	3	252	-240	Yes	positive	negative	positive	positive	negative	0
[8]	14	23	M	Yes	3	44	-44	Yes	positive	negative	negative	positive	positive	0
[8]	15	6	M	Yes	5	54	0	Yes	positive	positive	negative	positive	positive	8
[8]	16	25	M	Yes	1	0	0	Yes	positive	negative	positive	positive	positive	96
[8]	17	9	M	Yes	2	18	18	Yes	positive	negative	negative	positive	positive	2
[11]	18	47	M	n.a	2	60	0	No	positive	positive	positive	positive	negative	16
[4]	19	36	F	Yes	1	44.5	0	No	positive	n.a	n.a	positive	positive	116
[20]	20	10	F	Yes	0	36	12	No	positive	n.a	n.a	positive	negative	576
[19]	21	6	M	Yes	0	3	0	No	positive	n.a	n.a	positive	positive	0
[18]	22	29	M	Yes	1	4	2	Yes	positive	n.a	n.a	positive	positive	39
[16]	23	12	M	Yes	0	1.5	0	No	positive	positive	n.a	positive	n.a	91
[21]	24	14	F	Yes	3	44	-4	No	positive	positive	n.a	positive	negative	256
[21]	25	10	M	Yes	0	6	0	Yes	positive	positive	n.a	positive	n.a	96
[17]	26	19	M	Yes	2	37	18	Yes	positive	negative	negative	positive	n.a	292
[6]	27	27	M	Yes	0	4	0	Yes	n.a	n.a	positive	positive	n.a	5
[10]	28	38	M	Yes	1	6	0	Yes	positive	positive	n.a	n.a	negative	88
[5]	29	37	M	Yes	0	2	0	No	positive	positive	positive	positive	negative	50
[9]	30	39	M	Yes	2	60	0	No	positive	n.a	positive	positive	n.a	112
[7]	31	30	M	Yes	0	12	0	Yes	positive	positive	n.a	positive	n.a	n.a
Total	31	25 (3–54)	Female: 8 (25.8%)	29 (94%)	1 (0–5)	18 (0–252)	0 (-240–36)	23 (74%)	Positive: 29	Positive: 10	Positive: 16	Positive: 30	Positive: 11	43 (0–576)

Legend: CSF Cerebrospinal fluid, DE Demyelination, E NMDAR-encephalitis, F Female, IgG Immunoglobulin G, MO Months, M Male, MOG Myelin oligodendrocyte glycoprotein, MOG + MOG IgG positivity, N Number, NMDAR N-methyl-D-aspartate receptor, OCB Oligoclonal bands, Ref Reference, WBC White blood cell count

^a Diagnostic criteria for definite NMDAR encephalitis according to Graus et al. [26]

^b Demyelinating episodes during or after NMDAR-encephalitis were considered

^c Follow-Up after NMDAR-encephalitis